Connor, Clark & Lunn Investment Management Ltd.

Position in KURA — Kura Oncology, Inc.

CIK 1596800 VANCOUVER, A1

Position in KURA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,927,369

+$4,418,516 QoQ

Shares Held

996,114

+24.4% QoQ

Ownership

1.12%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#21

of 220 holders

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. KURA ranks #17 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc.	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,927,369	996,114	+24.4%	Shares	Sole	2026-08-13
2026-03-31	$6,508,853	800,597	+29.4%	Shares	Sole	2026-05-11
2025-12-31	$6,426,952	618,571	+69.5%	Shares	Sole	2026-02-10
2025-09-30	$3,229,648	364,932	+1130.6%	Shares	Sole	2025-11-13
2024-09-30	$579,458	29,655	+35.2%	Shares	Sole	2024-11-08
2024-06-30	$451,600	21,933	+15.9%	Shares	Sole	2024-08-09
2023-12-31	$272,026	18,917	-64.5%	Shares	Sole	2024-02-09
2022-09-30	$727,258	53,240	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.